688639 华恒生物
已收盘 03-20 15:00:01
资讯
新帖
简况
华恒生物公布国际专利申请：“一种生产L-丝氨酸工程菌株、构建方法和应用”
证券之星 · 05:54
华恒生物公布国际专利申请：“一种生产L-丝氨酸工程菌株、构建方法和应用”
华恒生物（688639）2025年年报简析：增收不增利，公司应收账款体量较大
证券之星 · 03-19 06:02
华恒生物（688639）2025年年报简析：增收不增利，公司应收账款体量较大
华恒生物(688639.SH)发布2025年度业绩，归母净利润1.32亿元，同比下降30.13%
智通财经 · 03-17
华恒生物(688639.SH)发布2025年度业绩，归母净利润1.32亿元，同比下降30.13%
3月11日华恒生物涨5.95%，交银先进制造混合A基金重仓该股
证券之星 · 03-11
3月11日华恒生物涨5.95%，交银先进制造混合A基金重仓该股
3月2日华恒生物跌6.83%，交银先进制造混合A基金重仓该股
证券之星 · 03-02
3月2日华恒生物跌6.83%，交银先进制造混合A基金重仓该股
每周股票复盘：华恒生物（688639）2025年净利降30.97%
证券之星 · 03-01
每周股票复盘：华恒生物（688639）2025年净利降30.97%
华恒生物发布2025年度业绩快报，盈利1.308亿元
证券之星 · 02-27
华恒生物发布2025年度业绩快报，盈利1.308亿元
每周股票复盘：华恒生物（688639）高管刘忠诚因个人原因离任
证券之星 · 01-18
每周股票复盘：华恒生物（688639）高管刘忠诚因个人原因离任
华恒生物（688639）公司公告高级管理人员离任，1月12日股价下跌0.85%
证券之星 · 01-12
华恒生物（688639）公司公告高级管理人员离任，1月12日股价下跌0.85%
1月6日华恒生物涨6.63%，交银先进制造混合A基金重仓该股
证券之星 · 01-06
1月6日华恒生物涨6.63%，交银先进制造混合A基金重仓该股
每周股票复盘：华恒生物（688639）2025年前三季营收增42.53%
证券之星 · 01-02
每周股票复盘：华恒生物（688639）2025年前三季营收增42.53%
华恒生物（688639）披露2025年度现场检查报告，12月31日股价上涨0.22%
证券之星 · 2025-12-31
华恒生物（688639）披露2025年度现场检查报告，12月31日股价上涨0.22%
每周股票复盘：华恒生物（688639）向控股子公司提供财务资助
证券之星 · 2025-12-28
每周股票复盘：华恒生物（688639）向控股子公司提供财务资助
华恒生物（688639）披露向控股子公司提供财务资助议案获股东会通过，12月25日股价下跌2.74%
证券之星 · 2025-12-25
华恒生物（688639）披露向控股子公司提供财务资助议案获股东会通过，12月25日股价下跌2.74%
华恒生物（688639）披露向控股子公司提供不超过4亿元财务资助，12月16日股价下跌1.62%
证券之星 · 2025-12-16
华恒生物（688639）披露向控股子公司提供不超过4亿元财务资助，12月16日股价下跌1.62%
华恒生物（688639）披露召开2025年第四次临时股东会通知，12月9日股价下跌2.22%
证券之星 · 2025-12-09
华恒生物（688639）披露召开2025年第四次临时股东会通知，12月9日股价下跌2.22%
12月5日华恒生物涨6.93%，交银先进制造混合A基金重仓该股
证券之星 · 2025-12-05
12月5日华恒生物涨6.93%，交银先进制造混合A基金重仓该股
华恒生物IPO：净利润连年走低毛利率已腰斩 供需格局反转产能过剩或仍将加剧
新浪证券 · 2025-11-20
华恒生物IPO：净利润连年走低毛利率已腰斩 供需格局反转产能过剩或仍将加剧
新股消息 | 华恒生物(688639.SH)拟港股上市 中国证监会要求补充说明近三年技术出口业务的开展情况等
智通财经网 · 2025-11-14
新股消息 | 华恒生物(688639.SH)拟港股上市 中国证监会要求补充说明近三年技术出口业务的开展情况等
华恒生物（688639）公司公告选举第五届董事会成员，11月12日股价上涨0.34%
证券之星 · 2025-11-12
华恒生物（688639）公司公告选举第五届董事会成员，11月12日股价上涨0.34%
加载更多
公司概况
公司名称：
安徽华恒生物科技股份有限公司
所属行业：
化学原料和化学制品制造业
上市日期：
2021-04-22
主营业务：
安徽华恒生物科技股份有限公司的主营业务是生物基产品的研发、生产、销售。公司的主要产品是氨基酸系列产品、维生素系列产品、生物基新材料单体、其他产品。
发行价格：
23.16
{"stockData":{"symbol":"688639","market":"SH","secType":"STK","nameCN":"华恒生物","latestPrice":31.26,"timestamp":1773990001000,"preClose":32.56,"halted":0,"volume":6954077,"delay":0,"changeRate":-0.0399,"floatShares":250000000,"shares":250000000,"eps":0.3011,"marketStatus":"已收盘","change":-1.3,"latestTime":"03-20 15:00:01","open":32.73,"high":32.76,"low":31.23,"amount":220000000,"amplitude":0.047,"askPrice":31.27,"askSize":216,"bidPrice":31.26,"bidSize":696,"shortable":0,"etf":0,"ttmEps":0.3011,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1774229400000},"marketStatusCode":5,"adr":0,"adjPreClose":32.56,"symbolType":"stock_kcb","openAndCloseTimeList":[[1773970200000,1773977400000],[1773982800000,1773990000000]],"highLimit":35.82,"lowLimit":29.3,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":250115693,"isCdr":false,"pbRate":2.95,"roa":"--","peRate":103.819329,"roe":"5.08%","epsLYR":0.53,"committee":0.03527,"marketValue":7819000000,"turnoverRate":0.0278,"status":1,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2026-03-23。","afterMarket":{"amount":0,"volume":0,"close":31.26,"buyVolume":0,"sellVolume":0,"time":1773992037559,"indexStatus":"已收盘 03-20 15:30:00","preClose":32.56},"floatMarketCap":7819000000},"requestUrl":"/m/hq/s/688639","defaultTab":"news","newsList":[{"id":"2621752753","title":"华恒生物公布国际专利申请：“一种生产L-丝氨酸工程菌株、构建方法和应用”","url":"https://stock-news.laohu8.com/highlight/detail?id=2621752753","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621752753?lang=zh_cn&edition=full","pubTime":"2026-03-21 05:54","pubTimestamp":1774043675,"startTime":"0","endTime":"0","summary":"证券之星消息，根据企查查数据显示华恒生物（688639）公布了一项国际专利申请，专利名为“一种生产L-丝氨酸工程菌株、构建方法和应用”，专利申请号为PCT/CN2025/096916，国际公布日为2026年3月19日。专利详情如下：图片来源：世界知识产权组织（WIPO）今年以来华恒生物已公布的国际专利申请1个。结合公司2025年年报财务数据，2025年公司在研发方面投入了1.51亿元，同比增21.89%。数据来源：企查查以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032100004171.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688639","BK0229"],"gpt_icon":0},{"id":"2620293364","title":"华恒生物（688639）2025年年报简析：增收不增利，公司应收账款体量较大","url":"https://stock-news.laohu8.com/highlight/detail?id=2620293364","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620293364?lang=zh_cn&edition=full","pubTime":"2026-03-19 06:02","pubTimestamp":1773871362,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期华恒生物发布2025年年报。截至本报告期末，公司营业总收入28.62亿元，同比上升31.4%，归母净利润1.32亿元，同比下降30.13%。本报告期华恒生物公司应收账款体量较大，当期应收账款占最新年报归母净利润比达204.85%。本次财报公布的各项数据指标表现一般。长期借款变动幅度为146.54%,原因:公司调整融资结构转为长期借款。营业收入变动幅度为31.4%,原因:公司氨基酸系列产品销量增加。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031900003207.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688639","BK0229"],"gpt_icon":0},{"id":"2620910424","title":"华恒生物(688639.SH)发布2025年度业绩，归母净利润1.32亿元，同比下降30.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2620910424","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620910424?lang=zh_cn&edition=full","pubTime":"2026-03-17 20:14","pubTimestamp":1773749673,"startTime":"0","endTime":"0","summary":"智通财经APP讯，华恒生物(688639.SH)发布2025年年度报告，报告期内，公司实现营业收入28.62亿元，同比增长31.40%。实现归属于上市公司股东的净利润1.32亿元，同比下降30.13%。实现归属于上市公司股东的扣除非经常性损益的净利润1.2亿元，同比下降32.56%。基本每股收益为0.53元。公司拟向全体股东每股派发现金红利0.16元(含税)。报告期内，公司主要产品缬氨酸、肌醇年平均价格较去年同期下降，且公司新项目效益尚未体现，对公司利润产生影响，同时，伴随公司经营规模扩大，公司各项费用较去年同期增加，公司归母净利润较去年同期减少0.57亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1415052.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"华恒生物(688639.SH)发布2025年度业绩，归母净利润1.32亿元，同比下降30.13%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688639"],"gpt_icon":0},{"id":"2618332912","title":"3月11日华恒生物涨5.95%，交银先进制造混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2618332912","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618332912?lang=zh_cn&edition=full","pubTime":"2026-03-11 16:21","pubTimestamp":1773217264,"startTime":"0","endTime":"0","summary":"证券之星消息，3月11日华恒生物涨5.95%，收盘报34.34元，换手率3.23%，成交量8.07万手，成交额2.67亿元。重仓华恒生物的公募基金请见下表：该股最近90天内共有3家机构给出评级，买入评级2家，增持评级1家。根据2025基金年报公募基金重仓股数据，重仓该股的公募基金共5家，其中持有数量最多的公募基金为交银施罗德基金的交银先进制造混合A。交银先进制造混合A目前规模为42.23亿元，最新净值6.0642，较上一交易日上涨1.7%，近一年上涨50.9%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031100026237.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688639","BK0229","399260"],"gpt_icon":0},{"id":"2616381798","title":"3月2日华恒生物跌6.83%，交银先进制造混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2616381798","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616381798?lang=zh_cn&edition=full","pubTime":"2026-03-02 16:34","pubTimestamp":1772440443,"startTime":"0","endTime":"0","summary":"证券之星消息，3月2日华恒生物跌6.83%，收盘报33.17元，换手率5.7%，成交量14.25万手，成交额4.78亿元。重仓华恒生物的公募基金请见下表：该股最近90天内共有3家机构给出评级，买入评级2家，增持评级1家。根据2025基金年报公募基金重仓股数据，重仓该股的公募基金共5家，其中持有数量最多的公募基金为交银施罗德基金的交银先进制造混合A。交银先进制造混合A目前规模为42.23亿元，最新净值6.0973，较上一交易日下跌0.49%，近一年上涨58.19%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030200022784.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["399260","BK0229","688639"],"gpt_icon":0},{"id":"2616845585","title":"每周股票复盘：华恒生物（688639）2025年净利降30.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616845585","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616845585?lang=zh_cn&edition=full","pubTime":"2026-03-01 02:43","pubTimestamp":1772304189,"startTime":"0","endTime":"0","summary":"截至2026年2月27日收盘，华恒生物报收于35.6元，较上周的34.3元上涨3.79%。本周，华恒生物2月25日盘中最高价报36.3元。华恒生物当前最新总市值89.04亿元，在化学制品板块市值排名50/170，在两市A股市值排名2312/5189。本周关注点来自业绩披露要点：华恒生物2025年归属净利润同比下降30.97%。公司公告汇总安徽华恒生物科技股份有限公司发布2025年度业绩快报，营业总收入为288,579.86万元，同比增长32.50%；归属于母公司所有者的净利润为13,081.59万元，同比下降30.97%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030100000974.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","688639"],"gpt_icon":0},{"id":"2614100833","title":"华恒生物发布2025年度业绩快报，盈利1.308亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2614100833","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614100833?lang=zh_cn&edition=full","pubTime":"2026-02-27 17:06","pubTimestamp":1772183178,"startTime":"0","endTime":"0","summary":"证券之星消息，华恒生物近日即将发布2025年年报，根据2月27日发布的业绩快报，归属净利润盈利1.308亿元，同比减少30.97%。华恒生物（688639）主营业务：从事生物基产品的研发、生产、销售。该股最近90天内共有3家机构给出评级，买入评级2家，增持评级1家。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022700027570.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","688639"],"gpt_icon":0},{"id":"2604925600","title":"每周股票复盘：华恒生物（688639）高管刘忠诚因个人原因离任","url":"https://stock-news.laohu8.com/highlight/detail?id=2604925600","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604925600?lang=zh_cn&edition=full","pubTime":"2026-01-18 03:56","pubTimestamp":1768679784,"startTime":"0","endTime":"0","summary":"截至2026年1月16日收盘，华恒生物报收于37.2元，较上周的36.64元上涨1.53%。本周，华恒生物1月13日盘中最高价报43.6元，股价触及近一年最高点。公司公告汇总安徽华恒生物科技股份有限公司于2026年1月12日收到副总经理刘忠诚先生的书面辞职报告，其因个人原因辞去副总经理职务，辞职后不再担任公司任何职务。该辞职报告自送达董事会之日起生效，不影响公司正常运作。刘忠诚先生已完成工作交接，未直接持有公司股份，无未履行承诺事项。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011800001175.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688639","BK0229"],"gpt_icon":0},{"id":"2602454095","title":"华恒生物（688639）公司公告高级管理人员离任，1月12日股价下跌0.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2602454095","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602454095?lang=zh_cn&edition=full","pubTime":"2026-01-12 22:15","pubTimestamp":1768227319,"startTime":"0","endTime":"0","summary":"截至2026年1月12日收盘，华恒生物报收于36.33元，较前一交易日下跌0.85%，最新总市值为90.87亿元。近日，安徽华恒生物科技股份有限公司发布公告称，公司于2026年1月12日收到副总经理刘忠诚先生的书面辞职报告，其因个人原因辞去副总经理职务，辞职后不再担任公司任何职务。该辞职报告自送达董事会之日起生效，不影响公司正常运作。刘忠诚先生已完成工作交接，未直接持有公司股份，无未履行承诺事项。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011200037159.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688639","BK0229"],"gpt_icon":0},{"id":"2601995864","title":"1月6日华恒生物涨6.63%，交银先进制造混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2601995864","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601995864?lang=zh_cn&edition=full","pubTime":"2026-01-06 15:37","pubTimestamp":1767685046,"startTime":"0","endTime":"0","summary":"证券之星消息，1月6日华恒生物涨6.63%，收盘报35.55元，换手率5.48%，成交量13.7万手，成交额4.78亿元。根据2025基金Q3季报公募基金重仓股数据，重仓该股的公募基金共4家，其中持有数量最多的公募基金为交银施罗德基金的交银先进制造混合A。交银先进制造混合A目前规模为44.97亿元，最新净值5.5455，较上一交易日上涨1.12%，近一年上涨57.68%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010600020416.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["399260","688639","BK0229"],"gpt_icon":0},{"id":"2600640036","title":"每周股票复盘：华恒生物（688639）2025年前三季营收增42.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2600640036","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600640036?lang=zh_cn&edition=full","pubTime":"2026-01-02 02:54","pubTimestamp":1767293650,"startTime":"0","endTime":"0","summary":"截至2025年12月26日收盘，华恒生物报收于33.14元，较上周的34.96元下跌5.21%。本周，华恒生物12月22日盘中最高价报35.35元。华恒生物当前最新总市值81.49亿元，在化学制品板块市值排名46/170，在两市A股市值排名2293/5181。检查范围涵盖公司治理、内部控制、信息披露、募集资金使用、关联交易、对外担保、重大对外投资及经营状况等方面。2025年前三季度公司实现营业收入同比增长42.53%，净利润同比略有下降。整体配合良好，无须向监管机构报告的重大事项。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010200000725.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688639"],"gpt_icon":0},{"id":"2595720475","title":"华恒生物（688639）披露2025年度现场检查报告，12月31日股价上涨0.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2595720475","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595720475?lang=zh_cn&edition=full","pubTime":"2025-12-31 17:43","pubTimestamp":1767174203,"startTime":"0","endTime":"0","summary":"截至2025年12月31日收盘，华恒生物报收于32.58元，较前一交易日上涨0.22%，最新总市值为81.49亿元。该股当日开盘32.65元，最高32.78元，最低32.17元，成交额达1.07亿元，换手率为1.32%。近日，兴业证券股份有限公司发布关于安徽华恒生物科技股份有限公司2025年度现场检查报告。公告显示，兴业证券作为保荐机构，于2025年12月23日至25日对华恒生物进行了现场检查。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025123100032545.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","688639"],"gpt_icon":0},{"id":"2594244804","title":"每周股票复盘：华恒生物（688639）向控股子公司提供财务资助","url":"https://stock-news.laohu8.com/highlight/detail?id=2594244804","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594244804?lang=zh_cn&edition=full","pubTime":"2025-12-28 02:20","pubTimestamp":1766859623,"startTime":"0","endTime":"0","summary":"截至2025年12月26日收盘，华恒生物报收于33.14元，较上周的34.96元下跌5.21%。本周，华恒生物12月22日盘中最高价报35.35元。华恒生物当前最新总市值82.89亿元，在化学制品板块市值排名46/170，在两市A股市值排名2251/5178。本周关注点公司公告汇总：华恒生物召开2025年第四次临时股东会，审议通过向控股子公司提供财务资助的议案。议案获得普通决议通过，并对中小投资者单独计票。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122800000422.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","688639"],"gpt_icon":0},{"id":"2594237553","title":"华恒生物（688639）披露向控股子公司提供财务资助议案获股东会通过，12月25日股价下跌2.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2594237553","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594237553?lang=zh_cn&edition=full","pubTime":"2025-12-25 22:09","pubTimestamp":1766671746,"startTime":"0","endTime":"0","summary":"截至2025年12月25日收盘，华恒生物报收于33.73元，较前一交易日下跌2.74%，最新总市值为84.36亿元。该股当日开盘34.68元，最高35.32元，最低32.98元，成交额达2.77亿元，换手率为3.28%。根据公司近日发布的公告，安徽华恒生物科技股份有限公司于2025年12月25日召开2025年第四次临时股东会，审议通过了关于向控股子公司提供财务资助的议案。议案获得普通决议通过，并对中小投资者单独计票。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122500035874.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","688639"],"gpt_icon":0},{"id":"2591980971","title":"华恒生物（688639）披露向控股子公司提供不超过4亿元财务资助，12月16日股价下跌1.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2591980971","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591980971?lang=zh_cn&edition=full","pubTime":"2025-12-16 22:11","pubTimestamp":1765894305,"startTime":"0","endTime":"0","summary":"截至2025年12月16日收盘，华恒生物报收于34.55元，较前一交易日下跌1.62%，最新总市值为86.41亿元。赤峰智合为公司间接控股子公司，资信良好，无不良记录。截至2025年11月30日，公司累计提供财务资助余额为12.45亿元，占最近一期经审计净资产的48.65%，无逾期未收回情况。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121600040544.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["91286","BK0229","688639"],"gpt_icon":0},{"id":"2590134423","title":"华恒生物（688639）披露召开2025年第四次临时股东会通知，12月9日股价下跌2.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590134423","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590134423?lang=zh_cn&edition=full","pubTime":"2025-12-09 22:11","pubTimestamp":1765289490,"startTime":"0","endTime":"0","summary":"截至2025年12月9日收盘，华恒生物报收于34.37元，较前一交易日下跌2.22%，最新总市值为85.96亿元。该股当日开盘35.07元，最高35.69元，最低34.32元，成交额达1.74亿元，换手率为2.0%。公司近日发布公告称，安徽华恒生物科技股份有限公司将于2025年12月25日召开2025年第四次临时股东会，会议采取现场投票与网络投票相结合的方式。股权登记日为2025年12月18日，A股股东可参会。股东可于2025年12月19日办理登记。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120900040301.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["91286","688639","BK0229"],"gpt_icon":0},{"id":"2589646678","title":"12月5日华恒生物涨6.93%，交银先进制造混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2589646678","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589646678?lang=zh_cn&edition=full","pubTime":"2025-12-05 15:34","pubTimestamp":1764920087,"startTime":"0","endTime":"0","summary":"证券之星消息，12月5日华恒生物涨6.93%，收盘报33.78元，换手率3.57%，成交量8.93万手，成交额2.95亿元。根据2025基金Q3季报公募基金重仓股数据，重仓该股的公募基金共4家，其中持有数量最多的公募基金为交银施罗德基金的交银先进制造混合A。交银先进制造混合A目前规模为44.97亿元，最新净值5.2609，较上一交易日上涨0.19%，近一年上涨43.36%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120500017926.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688639","399260","BK0229","91286"],"gpt_icon":0},{"id":"2584181909","title":"华恒生物IPO：净利润连年走低毛利率已腰斩 供需格局反转产能过剩或仍将加剧","url":"https://stock-news.laohu8.com/highlight/detail?id=2584181909","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584181909?lang=zh_cn&edition=full","pubTime":"2025-11-20 16:59","pubTimestamp":1763629140,"startTime":"0","endTime":"0","summary":" 近日，A股科创板上市公司华恒生物向香港联合交易所递交上市申请，拟实现“A+H”两地上市，华泰国际为其独家保荐人。 公开资料显示，华恒生物专注于依托生物制造技术，开展生物基产品的研发、生产和销售，以2024年收入为衡量标准，公司L-丙氨酸及L-缬氨酸的市场份额分别位居全球第一。然而，在光鲜外表之下，公司正面临着产品价格持续下跌、毛利率大幅下滑、行业竞争加剧等多重风险。华恒生物毛利率在可比企业中排名垫底。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/observe/2025-11-20/doc-infxzvky2227303.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["91286","688639"],"gpt_icon":0},{"id":"2583503522","title":"新股消息 | 华恒生物(688639.SH)拟港股上市 中国证监会要求补充说明近三年技术出口业务的开展情况等","url":"https://stock-news.laohu8.com/highlight/detail?id=2583503522","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583503522?lang=zh_cn&edition=full","pubTime":"2025-11-14 19:37","pubTimestamp":1763120241,"startTime":"0","endTime":"0","summary":"据港交所9月30日披露，安徽华恒生物科技股份有限公司(简称：华恒生物)向港交所主板提交上市申请书，华泰国际为独家保荐人。","market":"sh","thumbnail":"https://img.zhitongcaijing.com/image/20251114/20251114193747_53907.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20251114/20251114193747_53907.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1369525.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["91286","BK0229","688639"],"gpt_icon":0},{"id":"2582370978","title":"华恒生物（688639）公司公告选举第五届董事会成员，11月12日股价上涨0.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2582370978","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582370978?lang=zh_cn&edition=full","pubTime":"2025-11-12 22:48","pubTimestamp":1762958901,"startTime":"0","endTime":"0","summary":"截至2025年11月12日收盘，华恒生物报收于38.53元，较前一交易日上涨0.34%，最新总市值为96.37亿元。该股当日开盘37.98元，最高39.3元，最低36.93元，成交额达4.32亿元，换手率为4.52%。近日，安徽华恒生物科技股份有限公司发布2025年第三次临时股东会决议公告，公司于2025年11月12日召开2025年第三次临时股东会，审议通过了选举第五届董事会非独立董事和独立董事的议案。会议表决程序合法，决议有效。出席会议股东所持表决权占公司有效表决权总数的37.08%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111200041694.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["91286","688639","BK0229"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1774075787532,"stockEarnings":[{"period":"1week","weight":-0.1346},{"period":"1month","weight":-0.0886},{"period":"3month","weight":-0.1058},{"period":"6month","weight":-0.076},{"period":"1year","weight":0.0121},{"period":"ytd","weight":-0.0405}],"compareEarnings":[{"period":"1week","weight":-0.0338},{"period":"1month","weight":-0.0306},{"period":"3month","weight":0.0171},{"period":"6month","weight":0.0359},{"period":"1year","weight":0.1608},{"period":"ytd","weight":-0.003}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"安徽华恒生物科技股份有限公司","boardCode":"AI0026","boardName":"化学原料和化学制品制造业","stockholders":"14872人(较上一季度增加20.88%)","perCapita":"16817股","listingDate":"2021-04-22","address":"安徽省合肥市长丰县双凤工业区","registeredCapital":"25011万元","survey":" 安徽华恒生物科技股份有限公司的主营业务是生物基产品的研发、生产、销售。公司的主要产品是氨基酸系列产品、维生素系列产品、生物基新材料单体、其他产品。","listedPrice":23.16},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.37.0","shortVersion":"4.37.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"华恒生物(688639)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供华恒生物(688639)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"华恒生物,688639,华恒生物股票,华恒生物股票老虎,华恒生物股票老虎国际,华恒生物行情,华恒生物股票行情,华恒生物股价,华恒生物股市,华恒生物股票价格,华恒生物股票交易,华恒生物股票购买,华恒生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"华恒生物(688639)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供华恒生物(688639)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}